As of January 22, 2025, Spyre Therapeutics (SYRE) has a market cap of $1.32 billion USD. According to our data, Spyre Therapeutics is ranked No.4784 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.32 B |
-6.27%
|
Dec 31, 2024 | $1.40 B |
8.18%
|
Dec 29, 2023 | $1.30 B |
91.29%
|
Dec 30, 2022 | $0.68 B |
-90.53%
|
Dec 31, 2021 | $7.16 B |
-39.64%
|
Dec 31, 2020 | $11.86 B |
3.01%
|
Dec 31, 2019 | $11.52 B |
2.00%
|
Dec 31, 2018 | $11.29 B |
38.45%
|
Dec 29, 2017 | $8.16 B |
24.37%
|
Dec 30, 2016 | $6.56 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Argenx
ARGX
|
$38.53 B |
0.271 B
|
Netherlands
|
Catalent
CTLT
|
$11.52 B |
0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Market Cap | = | SYRE Stock Price | * | SYRE Shares Outstanding |
= | $21.82 | * | 60.30 M | |
= | $1.32 B |